Teva Pharmaceutical News

Companies

Warren Buffett’s bumpy ride with IBM draws to a close with stock sale

Warren Buffett's Berkshire Hathaway reported that it cut its stake in IBM by 94% during the fourth quarter, essentially drawing to a close a rare blemish on his investing record

2 min read15 Feb 2018
Companies

Aurobindo Pharma in talks to buy Shreya Life Sciences’s Russia business

The acquisition deal between Aurobindo Pharma and Shreya Life Sciences for the latter's Russia business is potentially valued at $80 milllion to $100 million

2 min read30 Aug 2017
Companies

Glenmark’s Glenn Saldanha seeks a new holy grail as generic drugs run dry

Sixteen years ago, when Glenn Saldanha of Glenmark Pharma took over his father's business he decided that instead of just imitating old drugs, he would also innovate new ones

5 min read18 May 2017
Companies

Teva Pharmaceutical to sell assets such as women’s health unit to cut debt

Teva Pharmaceutical plans to divest some assets including its global women's health and European cancer and pain-treatment divisions to reduce debt

3 min read11 May 2017
Companies

Teva Pharmaceutical to cut up to 6,000 jobs: Report

Teva Pharmaceutical is looking to eliminate between 5,000 and 6,000 positions over the next few years, says a newspaper report

1 min read23 Mar 2017
Companies

Teva Pharmaceutical loses another CEO, leaving investors to guess what’s next

Teva Pharmaceutical says Erez Vigodman will step down as CEO and the company will 'conduct a thorough review of the business'

2 min read7 Feb 2017
Companies

Teva to pay US government $519 million over foreign bribery charges

Teva's settlement with US department of justice and SEC relates to conduct in Ukraine, Mexico and a guilty plea by a subsidiary in Russia

1 min read22 Dec 2016
Companies

US patent office rules in favour of Mylan: Natco Pharma

Natco Pharma says US patent office ruled in Mylan's favour by striking down a patent related to Teva Pharmaceutical Industries drug Copaxone

2 min read2 Sep 2016
Companies

Cipla, Aurobindo Pharma acquire products divested by Teva in US

Teva Pharmaceutical Industries indicated that the divestment of overlapping products is expected to generate about $2.9 billion

1 min read29 Jul 2016
Companies

Teva, Mylan eye Pfizer’s Brazil venture: report

India's Sun Pharmaceutical Industries Ltd and three buyout firms are also eyeing Pfizer's Brazil venture

2 min read26 Jul 2016
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

infosys

Shares of Infosys were up by 0.43% at closing.

13 Articles
HomeMarketsPremiumFor youGet App